🕵️ Eupraxia Pharmaceuticals Inc. ($EPRX)
SEC insider & ownership activity, last 12 months · CIK 1581178 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Joseph S. Freedman trimmed 10.2% → 9.0%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Manchester Explorer, L.P. | 10.0% | 13G | Nov 13, 2025 | filing ↗ | |
| Morgan C. Frank | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| James E. Besser | 9.1% | 13G | Feb 17, 2026 | filing ↗ | |
| Joseph S. Freedman | 9.0% | 13D | Mar 13, 2026 | filing ↗ | |
| Manchester Management Company, LLC | 8.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Manchester Management PR, LLC | 8.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Manchester Explorer, L.P | 8.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Beutel, Goodman & Co Ltd. | 8.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Morgan C. Frank | 7.7% | 13G | May 12, 2026 | filing ↗ | |
| James E. Besser | 7.6% | 13G | May 12, 2026 | filing ↗ | |
| Manchester Management Company, LLC | 7.4% | 13G | May 12, 2026 | filing ↗ | |
| Manchester Management PR, LLC | 7.4% | 13G | May 12, 2026 | filing ↗ | |
| Manchester Explorer, L.P. | 7.1% | 13G | May 12, 2026 | filing ↗ | |
| Robert Disbrow | 7.0% | 13G | Nov 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.